The cell surface marker CD36 selectively identifies matured, mitochondria-rich hPSC-cardiomyocytes

Cell Res. 2020 Jul;30(7):626-629. doi: 10.1038/s41422-020-0292-y. Epub 2020 Mar 10.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • CD36 Antigens / metabolism*
  • Cell Differentiation* / drug effects
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Cells, Cultured
  • Doxorubicin / pharmacology
  • Humans
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Peptides / metabolism
  • Phenotype
  • Pluripotent Stem Cells / drug effects
  • Pluripotent Stem Cells / metabolism*

Substances

  • Biomarkers
  • CD36 Antigens
  • Peptides
  • Doxorubicin